Exploration of recurrent alterations in the branches of carcinoma-specific mutations with distinct mutational contexts such as ERBB2 amplification preceding APC and KRAS mutations would also be valuable information for understanding the evolutionary process of CRC. The gene discussed is ERBB2; the disease is carcinoma.